Alcohol Use Disorder Pipeline Drugs and Companies Insight Report (2023): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Alcohol Use Disorder pipeline constitutes 30+ key companies continuously working towards developing 30+ Alcohol Use Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

Alcohol Use Disorder Overview
Alcohol Use Disorder, also referred to as Alcoholism is the most severe form of alcohol abuse and involves the inability tomanage drinking habits. It is also known as Alcohol Addiction. These are common and potentially lethal disorders that mimic and exacerbate a wide range of additional medical and psychiatric conditions, and thereby shorten the lifespans of affected people by more than a decade.

"Alcohol Use Disorder Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alcohol Use Disorder Market.

The Alcohol Use Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Alcohol Use Disorder Pipeline Report:https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Alcohol Use Disorder treatment therapies with a considerable amount of success over the years. Alcohol Use Disorder Key players such as - Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others, are developing therapies for the Alcohol Use Disorder treatment
• Alcohol Use Disorder Emerging therapies such as - Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others are expected to have a significant impact on the Alcohol Use Disorder market in the coming years.
• In June 2021, Adial Pharmaceuticals FDA rejected its request for Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate, AD04, for the treatment of Alcohol Use Disorder (AUD) in pediatric patients and adult patients with Alcoholic Liver Disease (ALD)with select polymorphisms of the serotonin transporter and receptor genes
• Lohocla Research focus on the use of rational, evidence-based drug design for development of therapeutics to reduce craving and relapse to alcohol consumption in alcohol-dependent individuals, with the overall aim of reducing alcohol-related negative consequences and deaths

Alcohol Use Disorder Pipeline Therapeutics Assessment
• Alcohol Use Disorder Assessment by Product Type
• Alcohol Use Disorder By Stage and Product Type
• Alcohol Use Disorder Assessment by Route of Administration
• Alcohol Use Disorder By Stage and Route of Administration
• Alcohol Use Disorder Assessment by Molecule Type
• Alcohol Use Disorder by Stage and Molecule Type

DelveInsight's Alcohol Use Disorder Report covers around 30+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Emerging Alcohol Use Disorder Drugs Under Different Phases of Clinical Development Include:
• Pear-009: Pear Therapeutics
• CYB003: Cybin
• Nezavist: Lohocla Research
• BXCL501: BioXcel Therapeutics
• PT150: Pop Test Oncology
• DCR-AUD: Dicerna Pharmaceuticals
• ASP8062: Astellas Pharma
• KT 110: Kinnov Therapeutics
• Ibudilast: MediciNova
• AD04 : Adial Pharmaceuticals

Get a Free Sample PDF Report to know more about Alcohol Use Disorder Pipeline Assessment-
https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Alcohol Use Disorder Pipeline Analysis:
The Alcohol Use Disorder pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Alcohol Use Disorder treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alcohol Use Disorder Treatment.
• Disorder key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Alcohol Use Disorder Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Alcohol Use Disorder market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Alcohol Use Disorder product details are provided in the report. Download the Alcohol Use Disorder pipeline report to learn more about the emerging Alcohol Use Disorder therapies at:
https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Alcohol Use Disorder Pipeline Market Drivers
• Increasing Awareness
• Increasing research and development
• Initiative taken by market players
Alcohol Use Disorder Pipeline Market Barriers
• Less Treatment Utilization
• Side Effects of the Current Alcohol Use Disorder Therapies

Scope of Alcohol Use Disorder Pipeline Drug Insight
• Coverage: Global
• Key Alcohol Use Disorder Companies: Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna Pharmaceuticals, Astellas Pharma, Kinnov Therapeutics, MediciNova, Adial Pharmaceuticals, and others
• Key Alcohol Use Disorder Therapies: Pear-009, CYB003, Nezavist, BXCL501, PT150, DCR-AUD, ASP8062, KT 110, Ibudilast, AD04, and others
• Alcohol Use Disorder Therapeutic Assessment: Alcohol Use Disorder current marketed and Alcohol Use Disorder emerging therapies
• Alcohol Use Disorder Market Dynamics: Alcohol Use Disorder market drivers and Alcohol Use Disorder market barriers
Request for Sample PDF Report for Alcohol Use Disorder Pipeline Assessment and clinical trials- https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Alcohol Use Disorder Report Introduction
2 Alcohol Use Disorder Executive Summary
3 Alcohol Use Disorder Overview
4 Alcohol Use Disorder- Analytical Perspective In-depth Commercial Assessment
5 Alcohol Use Disorder Pipeline Therapeutics
6 Alcohol Use Disorder Late Stage Products (Phase II/III)
7 Alcohol Use Disorder Mid Stage Products (Phase II)
8 Alcohol Use Disorder Early Stage Products (Phase I)
9 Alcohol Use Disorder Preclinical Stage Products
10 Alcohol Use Disorder Therapeutics Assessment
11 Alcohol Use Disorder Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Alcohol Use Disorder Key Companies
14 Alcohol Use Disorder Key Products
15 Alcohol Use Disorder Unmet Needs
16 Alcohol Use Disorder Market Drivers and Barriers
17 Alcohol Use Disorder Future Perspectives and Conclusion
18 Alcohol Use Disorder Analyst Views
19 Appendix
20 About DelveInsight

Download Sample PDF Report to know more about Alcohol Use Disorder drugs and therapies- https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

Alcohol Use Disorder Market
https://www.delveinsight.com/report-store/alcohol-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcohol Use Disorder-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Alcohol Use Disorder Epidemiology
https://www.delveinsight.com/report-store/alcohol-use-disorder-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Alcohol Use Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Related Reports By DelveInsight -

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.